Crescent Capital BDC (NASDAQ:CCAP – Free Report) had its target price increased by Keefe, Bruyette & Woods from $18.50 to $19.00 in a research note published on Thursday, MarketBeat Ratings reports. The brokerage currently has an outperform rating on the stock.
A number of other research firms have also issued reports on CCAP. Wells Fargo & Company upped their target price on Crescent Capital BDC from $16.50 to $18.00 and gave the company an equal weight rating in a research note on Monday, May 13th. Raymond James upped their price objective on Crescent Capital BDC from $18.00 to $19.00 and gave the company an outperform rating in a research report on Friday, May 10th. Finally, Oppenheimer boosted their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an outperform rating in a research note on Friday, February 23rd.
Get Our Latest Analysis on CCAP
Crescent Capital BDC Stock Performance
Crescent Capital BDC Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.42 per share. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.41. The ex-dividend date is Friday, June 28th. This represents a $1.68 annualized dividend and a dividend yield of 9.34%. Crescent Capital BDC’s dividend payout ratio (DPR) is 58.36%.
Hedge Funds Weigh In On Crescent Capital BDC
Several large investors have recently added to or reduced their stakes in CCAP. International Assets Investment Management LLC purchased a new stake in Crescent Capital BDC in the 4th quarter valued at about $1,254,000. Anchor Investment Management LLC purchased a new stake in Crescent Capital BDC in the fourth quarter valued at approximately $342,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Crescent Capital BDC during the third quarter worth approximately $240,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in Crescent Capital BDC during the fourth quarter worth approximately $843,000. Finally, Virtus ETF Advisers LLC grew its stake in shares of Crescent Capital BDC by 43.5% during the 3rd quarter. Virtus ETF Advisers LLC now owns 40,965 shares of the company’s stock valued at $701,000 after buying an additional 12,420 shares during the period. 49.46% of the stock is currently owned by hedge funds and other institutional investors.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Stories
- Five stocks we like better than Crescent Capital BDC
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- MarketBeat Week in Review – 5/20 – 5/24
- Buy P&G Now, Before It Sets A New All-Time High
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- What is a Death Cross in Stocks?
- These 2 Retail Traders Favorites are Nearing Major Breakouts
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.